Clinical Trial Update: A Study to Evaluate MK1903 in Patients With Dyslipidemia (MK1903-004) [Phase 2]

View source ↗

Summary

Phase 2 study of MK1903 in patients with dyslipidemia completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• MK1903

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Dyslipidemia | Phase 2 | Status: COMPLETED | Results posted: 2010-09-22